» Articles » PMID: 36232761

Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis

Abstract

Multiple sclerosis (MS) is a degenerative disease of the central nervous system in which auto-immunity-induced demyelination occurs. MS is thought to be caused by a complex interplay of environmental and genetic risk factors. While most genetic studies have focused on identifying common genetic variants for MS through genome-wide association studies, the objective of the present study was to identify rare genetic variants contributing to MS susceptibility. We used whole exome sequencing (WES) followed by co-segregation analyses in nine multi-incident families with two to four affected individuals. WES was performed in 31 family members with and without MS. After applying a suite of selection criteria, co-segregation analyses for a number of rare variants selected from the WES results were performed, adding 24 family members. This approach resulted in 12 exonic rare variants that showed acceptable co-segregation with MS within the nine families, implicating the genes , , , , , , , , , , , and . Of these, three genes (, , and ) have been previously reported as carrying MS-related rare variants. Six additional genes (, , , , , and ) have also been implicated in MS through common genetic variants. The proteins encoded by all twelve genes containing rare variants interact in a molecular framework that points to biological processes involved in (de-/re-)myelination and auto-immunity. Our approach provides clues to possible molecular mechanisms underlying MS that should be studied further in cellular and/or animal models.

Citing Articles

Genes, Gene Loci, and Their Impacts on the Immune System in the Development of Multiple Sclerosis: A Systematic Review.

Arneth B Int J Mol Sci. 2024; 25(23).

PMID: 39684620 PMC: 11641802. DOI: 10.3390/ijms252312906.


Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?.

Broos J, van der Burgt R, Konings J, Rijnsburger M, Werz O, de Vries H J Neuroinflammation. 2024; 21(1):21.

PMID: 38233951 PMC: 10792915. DOI: 10.1186/s12974-023-02981-w.


Type 3 IP3 receptor: Its structure, functions, and related disease implications.

Wu L, Chen J Channels (Austin). 2023; 17(1):2267416.

PMID: 37818548 PMC: 10569359. DOI: 10.1080/19336950.2023.2267416.


A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis Susceptibility.

Esposito F, Osiceanu A, Sorosina M, Ottoboni L, Bollman B, Santoro S Genes (Basel). 2022; 13(12).

PMID: 36553660 PMC: 9777893. DOI: 10.3390/genes13122392.

References
1.
Sadovnick A, Traboulsee A, Zhao Y, Bernales C, Encarnacion M, Ross J . Genetic modifiers of multiple sclerosis progression, severity and onset. Clin Immunol. 2017; 180:100-105. DOI: 10.1016/j.clim.2017.05.009. View

2.
Defazio G, Livrea P, Giorelli M, Martino D, Roselli F, Ricchiuti F . Interferon beta-1a downregulates TNFalpha-induced intercellular adhesion molecule 1 expression on brain microvascular endothelial cells through a tyrosine kinase-dependent pathway. Brain Res. 2000; 881(2):227-30. DOI: 10.1016/s0006-8993(00)02814-6. View

3.
Chen J, Wang Z, Guo X, Li F, Wei Q, Chen X . TRIM66 reads unmodified H3R2K4 and H3K56ac to respond to DNA damage in embryonic stem cells. Nat Commun. 2019; 10(1):4273. PMC: 6753139. DOI: 10.1038/s41467-019-12126-4. View

4.
Lebrun-Julien F, Bachmann L, Norrmen C, Trotzmuller M, Kofeler H, Ruegg M . Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination. J Neurosci. 2014; 34(25):8432-48. PMC: 6608214. DOI: 10.1523/JNEUROSCI.1105-14.2014. View

5.
Klemann C, Visser J, Van Den Bosch L, Martens G, Poelmans G . Integrated molecular landscape of amyotrophic lateral sclerosis provides insights into disease etiology. Brain Pathol. 2016; 28(2):203-211. PMC: 8028446. DOI: 10.1111/bpa.12485. View